Relevant bibliographies by topics / Anticancer treatments

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Anticancer treatments'

Author: Grafiati
Published: 4 June 2021
Last updated: 3 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anticancer treatments.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anticancer treatments"

1

Toca-Muñoz, M., B. Mora-Rodríguez, A. Luna-Higuera, E. Valverde Alcalá, and I. M. Muñoz-Castillo. "Targeted anticancer treatments." European Journal of Hospital Pharmacy 19, no. 2 (2012): 185.1–185. http://dx.doi.org/10.1136/ejhpharm-2012-000074.264.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ewer, Michael S., and Steven M. Ewer. "Cardiotoxicity of anticancer treatments." Nature Reviews Cardiology 12, no. 9 (2015): 547–58. http://dx.doi.org/10.1038/nrcardio.2015.65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zarifa, Abdulrazzak, Aya Albittar, Peter Y. Kim, et al. "Cardiac toxicities of anticancer treatments." Current Opinion in Cardiology 34, no. 4 (2019): 441–50. http://dx.doi.org/10.1097/hco.0000000000000641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ewer, Michael S., and Steven M. Ewer. "Erratum: Cardiotoxicity of anticancer treatments." Nature Reviews Cardiology 12, no. 11 (2015): 620. http://dx.doi.org/10.1038/nrcardio.2015.133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

D'Hondt, Lionel, Christophe Lonchay, Marc Andr�, and Jean-Luc Canon. "Oral mucositis induced by anticancer treatments: physiopathology and treatments." Therapeutics and Clinical Risk Management 2, no. 2 (2006): 159–68. http://dx.doi.org/10.2147/tcrm.2006.2.2.159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chen, Sheng-hong, William Forrester, and Galit Lahav. "Schedule-dependent interaction between anticancer treatments." Science 351, no. 6278 (2016): 1204–8. http://dx.doi.org/10.1126/science.aac5610.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jouinot, Anne, Clara Vazeille, and François Goldwasser. "Resting energy metabolism and anticancer treatments." Current Opinion in Clinical Nutrition & Metabolic Care 21, no. 3 (2018): 145–51. http://dx.doi.org/10.1097/mco.0000000000000457.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Calvo, Anne Sophie, Juliette Rochefort, Marie José Javelot, Vianney Descroix, and Géraldine Lescaille. "Management of mTOR inhibitors oral mucositis: current state of knowledge." Journal of Oral Medicine and Oral Surgery 25, no. 1 (2019): 11. http://dx.doi.org/10.1051/mbcb/2018027.

Full text
Abstract:
Introduction: Mucositis is a well-known side effect of classic anticancer treatments (chemotherapy and radiotherapy). Thanks to the major developments in personalizing treatments through the development of targeted treatment, various specific intraoral lesions have been described. Purpose: mTOR inhibitors are targeted anticancer treatments that are used to treat various cancer types. They can cause intraoral ulcerations that can be serious, and that can lead to a dose reduction or the anticancer treatment being stopped altogether. The management of these disabling and painful lesions is a majo
APA, Harvard, Vancouver, ISO, and other styles
9

Robert, Caroline, Vincent Sibaud, Christina Mateus, et al. "Nail toxicities induced by systemic anticancer treatments." Lancet Oncology 16, no. 4 (2015): e181-e189. http://dx.doi.org/10.1016/s1470-2045(14)71133-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Carlson, Robert H. "Common Bacteria Integral to New Anticancer Treatments." Oncology Times 23, no. 6 (2001): 67–68. http://dx.doi.org/10.1097/01.cot.0000315765.11795.e5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anticancer treatments"

1

Calvet, Christophe. "Immunological aspects of anticancer electroporation-based treatments." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA114816.

Full text
Abstract:
L'électrochimiothérapie est un traitement anticancéreux utilisé en routine en Europe dans près de 130 centres de traitement du cancer. Le taux de réponse objective atteint 85 % pour le traitment de tumeurs cutanées et sous-cutanées et des études sont en cours afin d'appliquer ce traitement à des tumeurs profondes. Au cours de ce doctorat, les méchanismes sous-jacents à cette excellente efficacité antitumorale ont été étudiés. Dans un premier temps, l'objectif a été d'évaluer la capacité de l'électrochimiothérapie à induire la mort des cellules souches cancéreuses, considérées comme les racines
APA, Harvard, Vancouver, ISO, and other styles
2

Iurisci, Ida. "Targeting anticancer treatments on circadian cloks : experimental and clinical approaches." Paris 11, 2008. http://www.theses.fr/2008PA11T016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kotadia, Nayna. "A Study on the Protein Interaction with Different Platinum Compounds." TopSCHOLAR®, 2008. http://digitalcommons.wku.edu/theses/8.

Full text
Abstract:
Since the discovery of anti-tumor activity of cisplatin in 1960, significant progress has been made in treating metastatic or advanced cancer with cisplatin and platinum compounds. Platinum compounds covalently bind to DNA and disrupt DNA function. They are also known to bind with amino acids like methionine, histidine and cysteine to form cisplatin-protein adducts which are responsible for most of its cytotoxicity and side effects. Recent articles on cisplatin-protein have shown that adding bulky adjuncts to cisplatin or using different platinum compounds varies the degree and extent of react
APA, Harvard, Vancouver, ISO, and other styles
4

Sabatino, Maria Antonietta. "Combination treatments in in vitro and in vivo models between molecules reverting epigenetic gene silencing and DNA-interacting anticancer drugs." Thesis, Open University, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.502390.

Full text
Abstract:
Epigenetic transcriptional gene silencing plays a fundamental role in cancer development and has been considered as a target for cancer therapy in the last few years, mainly due to its reversibility by small molecules. Among the several methylated genes investigated, glutathione-S-transferase CGST) PI, a protein belonging to cellular detoxification systems, has been shown to be extensively promoter-methylated in prostate cancer. My study therefore describes a new therapeutic approach against prostate cancer, based on the combination of demethylating agents and brostallicin, a DNA minor groove
APA, Harvard, Vancouver, ISO, and other styles
5

Magri, Neal Francis. "Modified taxols as anticancer agents." Diss., Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/53892.

Full text
Abstract:
Modifications of the potent anticancer agent taxol were carried out in order to gain an understanding of the chemical reactivity of the drug and the factors which contribute to its biological activity. The C-2' and/or the C-7 hydroxyl groups of taxol were substituted with acetyl, ßalanyl, silyl, succinyl, trichloroethyloxycarbonyl or carbonate linked dibenzylidene protected glucosyl groups. The C-7 position was selectively epimerized under free radical conditions and a 2'-epiacetyltaxol was produced via base catalysed epimerization. The C-2' amide became nucleophilic in the presence of base an
APA, Harvard, Vancouver, ISO, and other styles
6

Coldman, Andrew James. "The development of resistance to anticancer agents." Thesis, University of British Columbia, 1986. http://hdl.handle.net/2429/26975.

Full text
Abstract:
The mechanism of resistance of tumor cells to chemotherapeutic agents is explored using probabilistic methods where it is assumed that resistant cells arise spontaneously with a defined frequency. The resistance process is embedded in a discrete time Markov branching process which models the growth of the tumor and contains three seperate cell types: stem, transitional and end cells. Using the asymptotic properties of such models it is shown that the proportion of each type of cell converge to constants almost surely. It is shown that the parameters relating to stem cell behaviour determine th
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Wen. "Identification of novel pyruvate dehydrogenase kinase 1 (PDK1) inhibitors for anticancer therapeutics." Thesis, University of Macau, 2018. http://umaclib3.umac.mo/record=b3953604.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cadorette, Veronica R. "Chemical investigation of Dicranum fulvum for anticancer activity." Thesis, Virginia Tech, 1989. http://hdl.handle.net/10919/44706.

Full text
Abstract:
<p>Biological screening of extracts of various bryophytes showed that the species Dicranum fulvum gave extracts with activity in both <u>in vitro</u> and <u>in vivo</u> bioassays. This plant was thus selected for extraction and fractionation, monitored by i<u>in vitro</u> bioassays.</p> <p>Isolation was guided by a combination of bioassay and chemical methods, and led to the isolation of three compounds, betulin, 9,l9- cyclolanostâ 23â eneâ 3,25â diol, and B-sitosterol. Purification was achieved by open column, flash column, gel filtration, thin layer chromatography, the chromatotr
APA, Harvard, Vancouver, ISO, and other styles
9

Lewis, Andrew Martin. "The synthesis and biological evaluation of a novel anticancer small molecule." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cassim, Layla. "Melatonin and anticancer therapy interactions with 5-Fluorouracil." Thesis, Rhodes University, 2008. http://hdl.handle.net/10962/d1003224.

Full text
Abstract:
On the basis of clinical studies, some researchers have advocated that the neurohormone and antioxidant melatonin, shown to possess intrinsic anticancer properties, be used as co-therapy in cancer patients being treated with the antineoplastic agent 5-fluorouracil, as increased patient survival times and enhanced quality of life have been observed. The focus of this research was thus to investigate the mechanisms of this seemingly beneficial drug interaction between 5-fluorouracil and melatonin. Metabolism studies were undertaken, in which it was established that there is no hepatic metabolic
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anticancer treatments"

1

Hodgkin's lymphoma: From palliation to cure during the 1st century of active anticancer treatments. Médecine et hygiéne, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chʻang, Min-i. Anticancer medicinal herbs. Hunan Science and Technology Publishing House, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Servan-Schreiber, David. Anticancer: A new way of life. Viking, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Servan-Schreiber, David. Anticancer: A new way of life. Viking, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Anticancer: A new way of life. HarperCollins Canada, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anticancer: A new way of life. Viking, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Servan-Schreiber, David. Anticancer: A new way of life. Viking, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Servan-Schreiber, David. Anticancer: A new way of life. Viking, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Anticancer: A new way of life. Michael Joseph, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Convention, United States Pharmacopeial. Fact sheets on anticancer drugs. National Cancer Institute [distributor], 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Anticancer treatments"

1

Ahles, Tim, Sanne Schagen, and Janette Vardy. "Neurocognitive Effects of Anticancer Treatments." In Clinical Psycho-Oncology. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781119941101.ch6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khoury, Kareem, Tad A. Holak, and Alexander Dömling. "p53/MDM2 Antagonists: Towards Nongenotoxic Anticancer Treatments." In Protein-Protein Interactions in Drug Discovery. Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527648207.ch7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Scher, Howard I., Nancy L. Geller, Franco M. Muggia, and Marcel Rozencweig. "Clinical Evaluation of Anticancer Treatments: Phase II Clinical Trials." In Clinical Evaluation of Antitumor Therapy. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2317-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Di Cresce, Christine, Colin Way, Mateusz Rytelewski, et al. "Antisense Technology: From Unique Laboratory Tool to Novel Anticancer Treatments." In From Nucleic Acids Sequences to Molecular Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27426-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kunz, Christina, and Lutz Edler. "On the Application of Flexible Designs When Searching for the Better of Two Anticancer Treatments." In Statistical Modeling for Biological Systems. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-34675-1_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nguyen, T. A., Tien V. Nguyen, D. T. Tran, et al. "Microfluidic Impedance Biosensors for Monitoring a Single and Multiple Cancer Cells in Anticancer Drug Treatments." In 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6). Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4361-1_117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lozhkomoev, Aleksandr S., Georgy Mikhaylov, Vito Turk, Boris Turk, and Olga Vasiljeva. "Application of Crumpled Aluminum Hydroxide Nanostructures for Cancer Treatment." In Springer Tracts in Mechanical Engineering. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-60124-9_10.

Full text
Abstract:
AbstractThe tumormicroenvironment regulates tumor progression and the spread of cancer in the body. Applications of nanomaterials that can dysregulate tumor-microenvironment are emerging as a promising anti-cancer approaches, which can improve the efficacy of existing cancer treatments. We have reported that agglomerates of radially assembled Al hydroxide crumpled nanosheets with the disordered defective surface structure have a large positive charge and therefore can lead to ion imbalance at the cell perimembranous space through the selective adsorption of extracellular anionic species. This effect was demonstrated in vitro by reduced viability and proliferationof tumor cells, and further validated in a murine melanoma cancer model. Furthermore, crumpled Al hydroxide nanostructures showed a much stronger suppressive effect on tumor growth in combination with a minimally effective dose of doxorubicin. Taken together, the described approach of tumor microenvironment dysregulation through selective adsorption properties of folded crumpled nanostructures opened a new avenue for development of innovative anticancer therapy strategies.
APA, Harvard, Vancouver, ISO, and other styles
8

Zimmermann, Jürg, Pascal Furet, and Elisabeth Buchdunger. "STI571: A New Treatment Modality for CML?" In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Koul, Bhupendra. "Plants with Anticancer Potential." In Herbs for Cancer Treatment. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9147-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miller, Donald M., Shelia D. Thomas, Kara Sedoris, et al. "Using Human Observations to Gain Biologic Insights and New Treatments; Discovery of a Quadruplex-Forming DNA Aptamer as an Anticancer Agent." In The Primo Vascular System. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0601-3_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anticancer treatments"

1

Helleday, Thomas. "Abstract CN05-04: Novel DNA repair targets for anticancer treatments." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-cn05-04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"PAMAM Dendrimers as anti-HER2 Positive Breast Cancer Treatment." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0176.

Full text
Abstract:
Background: Poly (amidoamine) dendrimers (PAMAMs) are widely used in drug delivery systems and gene transfection as drug carriers. They also exert several biological effects like modulating gene expression, particularly EGFR (ErbB1) signaling pathway, which raises the question of whether these polymers can also inhibit the phosphorylation of HER2 (ErbB2) in breast cancer. However, this area hasn’t been investigated before. Methods: In this study, we evaluated the anticancer effects of different generations and surface chemistries of PAMAMs on HER2 positive breast cancer cells (SkBr3 and ZR-75
APA, Harvard, Vancouver, ISO, and other styles
3

Milcarek, Andrew T., Kevin Daus, and Mary L. Alpaugh. "Abstract 2173: Developing a high-throughput, high content screening technology to identify new anticancer drug treatments." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-2173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Milcarek, Andrew T., Kevin Daus, and Mary L. Alpaugh. "Abstract 2173: Developing a high-throughput, high content screening technology to identify new anticancer drug treatments." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-2173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dereli-Korkut, Zeynep, and Sihong Wang. "Microfluidic Cell Arrays to Mimic 3D Tissue Microenvironment." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80411.

Full text
Abstract:
We developed a functional high throughput 3D microfluidic living cell array (MLC) for anti-cancer drug screening and mechanism discovery. Contemporary drug screening methods suffer from low sample throughput and lack of abilities of mimicking the 3D microenvironment of mammalian tissues. The poor performance of anti-cancer drugs limits the efficacy at controlling the complex disease system like cancer. Systematic studies of apoptotic signaling pathways can be prominent approaches for searching active and effective treatments with less drug resistance. Hence, innovative bio-devices are needed t
APA, Harvard, Vancouver, ISO, and other styles
6

Nchinech, N., Y. Moutaouakkil, Y. Tadlaoui, et al. "DI-075 Evaluation of patients’ needs regarding information on anticancer treatments delivered to our health institution as part of a therapeutic education project." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ahmed, Elham, Abdul Khan, Kirti S. Prabhu, et al. "Sanguinarine Mediated Anti-Tumor activity Via Targeting JAK/STAT3 Pathway in Thyroid Cancer." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0155.

Full text
Abstract:
Sanguinarine (SNG), a natural compound with an array of pharmacological activities, has promising therapeutic potential against a number of pathological conditions, including malignancies. This research aimed to investigate the antiproliferative and anti-cancer potential of SNG against two well characterized papillary thyroid cancer (PTC) cell lines, BCPAP and TPC-1 .In both cell lines , SNG was able to inhibit cell proliferation in time and dose dependent manner. Western blot analysis revealed increased expression of apoptosis and autophagy markers , caspase-3,cleaved caspase-3 , P62, and LC3
APA, Harvard, Vancouver, ISO, and other styles
8

Cherdyntseva, N., N. Litviakov, F. Ivanova, E. Denisov, P. Gervas, and E. Cherdyntsev. "The molecular aspects of personalized anticancer treatment." In PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS (PC’16): Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016. Author(s), 2016. http://dx.doi.org/10.1063/1.4960229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ma, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin, and Wei Li. "A Perfused Two-Chamber System for Anticancer Drug Screening." In ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.

Full text
Abstract:
A cell culture microfluidic device has been developed to test the cytotoxicity of anticancer drugs while reproducing multi-organ interactions in vitro. Cells were cultured in separate chambers representing the liver and tumor. The two chambers were connected through a channel to mimick the blood flow. Glioblastoma (GBM) cancer cells (M059K) and hepatoma cells (HepG2) were cultured in the tumor and the liver chambers, respectively. The cytotoxic effect of cancer treatment drug Temolozomide (TMZ) was tested using this two chamber system. The experimental results showed that with the liver cells,
APA, Harvard, Vancouver, ISO, and other styles
10

Antonijevic, Marko, Jelena Đorovic Jovanovic, Ana Kesic, Dejan Milenkovic та Zoran Markovic. "КOMPLEKSI ZLATA KAO POTENCIJALNI SUPLEMENTI SA ANTIKANCEROGENIM I ANTIVIRUSNIM DELOVANJEM". У XXVI savetovanje o biotehnologiji sa međunarodnim učešćem. University of Kragujevac, Faculty of Agronomy, 2021. http://dx.doi.org/10.46793/sbt26.429a.

Full text
Abstract:
The pharmacologic properties of gold compounds have been known since the end of the 19th century. They have been used for different studies, even though they are usually used for the treatment of arthritis. In the last decade, gold complexes have received increased attention due to the variety of their applications. Primary, they have been investigated as potential anticancer and chemotherapeutic agents. It is well known that gold(III) complexes are very similar to platinum(II) compounds, so they could exhibit prospective anticancer, cytotoxic and antitumor properties. In this paper, were inve
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Anticancer treatments"

1

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada486569.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada481424.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anticancer treatments' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography